Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive Neuroendocrine Tumors × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 531 Gastro-enteropancreatic neuroendocrine tumor 58 Carcinoid Tumor 58 Neoplasms 49 Carcinoma, Neuroendocrine 44 Pancreatic Neoplasms 36 Adenoma, Islet Cell 33 Neoplasm Metastasis 28 Pheochromocytoma 25 Colorectal Neoplasms 24 Paraganglioma 23 Stomach Neoplasms 21 Breast Neoplasms 21 Prostatic Neoplasms 20 Lung Neoplasms 20 Carcinoma, Hepatocellular 20 Sarcoma 19 Carcinoma 19 Thyroid Neoplasms 18 Gastrointestinal Neoplasms 18 Neuroblastoma 15 Cholangiocarcinoma 14 Carcinoma, Renal Cell 14 Small Cell Lung Carcinoma 13 Melanoma 13 Esophageal Neoplasms 13 Serotonin Syndrome 12 Colonic Neoplasms 12 Brain Neoplasms 11 Adenocarcinoma 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡